skip to Main Content

AIM round-up: Blue Prism Group, Verditek, Braveheart Investment Group


London’s AIM Index has had a good start to the shortened trading week and failing to find itself pressured by woes afflicting the main board. The junior market finished up 11 points at 1292.24, marking fresh highs for the year.

  • Blue Prism Group +32%
  • Verditek + 32%
  • Reabold Resources -16%
  • Lekoil -15%
  • Braveheart Investment Group +21%

Blue Prism [LON:PRSM] was the day’s best performer, adding 32% as speculation over a possible agreed buyout of the company continues. Management issued an RNS this afternoon confirming that discussions were ongoing but stressing that there was no guarantee an offer would be made.

Verditek [LON:VDTK] was the day’s second best riser, adding just under 32% by the bell. There’s no fresh news here but the company did publish interim earnings late last week which didn’t illicit much of a response at the time. Shares are now returning to levels last seen before the bond issuance at the start of the month.

Reabold Resources [LON:RBD] was the day’s laggard, finishing some 16% offside after an operations update was published. This was something of a mixed bag, but the stock has been under pressure since April – investors had clearly been hoping for more here with today’s news extending Friday’s losses.

Lekoil [LON:LEK] also struggled today, dropping back some 15%, although with a 20% spread being quoted and limited volumes, there’s not much to be seen here on the £6m market cap company. It’s also worth noting that the stock jumped higher ahead of the weekend break, so this largely just reverses that move.

A notable mention for Braveheart Investment Group [LON:BRH] which added 21% on Tuesday. There’s no news out here yet but volumes have been upbeat and shares are starting to recover those losses accrued earlier in the month. Could news from a portfolio company be coming soon?

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

The Armchair Trader's 'How to' Guides

Read our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

Listen to our latest podcast episodes

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top